Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
NCT02920190
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Lack of funds to cover the costs of the study medications
Conditions
Monoclonal Gammopathies
Overweight
Obesity
Interventions
DRUG:
Liraglutide
Sponsor
University of Miami